{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:27:14Z","timestamp":1794551234978,"version":"4.9.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:p>This study aims to investigate the toxicity of di(2-ethylhexyl) phthalate (DEHP) and the potential molecular mechanisms of DEHP-induced bladder cancer (BLCA) using network toxicology and molecular docking strategies. The toxicity of DEHP was assessed using Prox-II software, and potential targets for DEHP-induced BLCA were identified by integrating data from ChEMBL database, Search Tool for Interactions of Chemicals, SwissTargetPrediction, GeneCards, Therapeutic Target Database, Online Mendelian Inheritance in Man, and The Cancer Genome Atlas. STRING database and Cytoscape were employed to construct target networks and determine core targets. The expression levels of core targets were analyzed using R. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed on potential and core targets. Molecular docking was carried out using CB-Dock 2 to verify the interactions between DEHP and core targets. A total of 105 potential targets related to DEHP-induced BLCA were identified, from which 7 core targets were selected: cyclin-dependent kinase 1, interleukin 6, cyclin-dependent kinase 2, cyclin B1, Erb-B2 receptor tyrosine kinase 2, cyclin B2, and B-cell lymphoma 2. IL-6 and B-cell lymphoma 2 showed downregulated expression in tumor tissues, while cyclin-dependent kinase 1, cyclin-dependent kinase 2, cyclin B1, Erb-B2 receptor tyrosine kinase 2, and cyclin B2 were upregulated. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses indicated that these targets were enriched in cell signaling and cancer-related pathways. Molecular docking confirmed that DEHP interacts with these core targets. DEHP may promote the development of BLCA by interacting with key proteins and signaling pathways. This study provides a theoretical basis for understanding the molecular mechanisms of DEHP-induced BLCA and offers references for future prevention and treatment strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000047378","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:00:54Z","timestamp":1770404454000},"page":"e47378","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of the molecular mechanism underlying di(2-ethylhexyl) phthalate-induced bladder carcinogenesis via network toxicology and molecular docking approaches: An observational study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8142-0094","authenticated-orcid":false,"given":"Manfei","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmai","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianghua","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1930-5377","authenticated-orcid":false,"given":"Xianping","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"162627","DOI":"10.1016\/j.scitotenv.2023.162627","article-title":"Contribution of plastic and microplastic to global climate change and their conjoining impacts on the environment - A review.","volume":"875","author":"Sharma","year":"2023","journal-title":"Sci Total Environ"},{"key":"R2-20260915","first-page":"100612","article-title":"Emerging contaminants: a one health perspective.","volume":"5","author":"Wang","year":"2024","journal-title":"Innovation (Camb)"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.scitotenv.2018.01.092","article-title":"A critical perspective on early communications concerning human health aspects of microplastics.","volume":"626","author":"Rist","year":"2018","journal-title":"Sci Total Environ"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/reveh-2021-0129","article-title":"Exposure to air pollution and risk of ovarian cancer: a review.","volume":"38","author":"Dehghani","year":"2022","journal-title":"Rev Environ Health"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018.","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41585-020-00385-6","article-title":"Plastic exposure and urological malignancies - an emerging field.","volume":"17","author":"Patel","year":"2020","journal-title":"Nat Rev Urol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"804457","DOI":"10.3389\/fendo.2021.804457","article-title":"Exposure to Di-2-ethylhexyl phthalate and benign prostatic hyperplasia, NHANES 2001-2008.","volume":"12","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"47832","DOI":"10.1007\/s11356-023-25633-1","article-title":"Assessing human exposure to phthalate esters in drinking water migrated from various pipe materials and water filter elements during water treatments and storage.","volume":"30","author":"Zhang","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"18686","DOI":"10.1021\/acs.est.4c04164","article-title":"Increasing the recycling of PVC flooring requires phthalate removal for ensuring consumers\u2019 safety: a cross-checked substance flow analysis of plasticizers for Switzerland.","volume":"58","author":"Klotz","year":"2024","journal-title":"Environ Sci Technol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-physiol-012110-142200","article-title":"Endocrine disruptors: from endocrine to metabolic disruption.","volume":"73","author":"Casals-Casas","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/toxics7020021","article-title":"a review of biomonitoring of phthalate exposures.","volume":"7","author":"Wang","year":"2019","journal-title":"Toxics"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-4274(01)00298-3","article-title":"Hormones and testis development and the possible adverse effects of environmental chemicals.","volume":"120","author":"Sharpe","year":"2001","journal-title":"Toxicol Lett"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12889-024-17801-w","article-title":"Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer.","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Public Health"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.etap.2018.08.007","article-title":"Phthalates promote prostate cancer cell proliferation through activation of ERK5 and p38.","volume":"63","author":"Zhu","year":"2018","journal-title":"Environ Toxicol Pharmacol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tiv.2015.12.012","article-title":"Mono-2-ethyhexyl phthalate advancing the progression of prostate cancer through activating the hedgehog pathway in LNCaP cells.","volume":"32","author":"Yong","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy.","volume":"13","author":"Krewski","year":"2010","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","article-title":"Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease.","volume":"145","author":"Tao","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"89643","DOI":"10.1007\/s11356-022-22092-y","article-title":"Exposure to DEHP is potential to increase the risk of overactive bladder, evidence from NHANES 2003-2008.","volume":"29","author":"Yang","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces.","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R20-20260915","first-page":"757","article-title":"Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.","volume":"12","author":"Nowotka","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal Protein Knowledgebase in 2023.","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape automation: empowering workflow-based network analysis.","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","article-title":"Gene ontology consortium: going forward.","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs.","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation.","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"D564","DOI":"10.1093\/nar\/gkae1091","article-title":"Updated resources for exploring experimentally-determined PDB structures and computed structure models at the RCSB protein data bank.","volume":"53","author":"Burley","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"237.e1","DOI":"10.1016\/j.urolonc.2015.11.011","article-title":"The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer.","volume":"34","author":"Lei","year":"2016","journal-title":"Urol Oncol"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1038\/celldisc.2015.28","article-title":"Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1.","volume":"1","author":"Lin","year":"2015","journal-title":"Cell Discov"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.3390\/cancers14204979","article-title":"Characterizing and targeting genes regulated by transcription factor MYBL2 in lung adenocarcinoma cells.","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies.","volume":"14","author":"Hu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"16366","DOI":"10.18632\/oncotarget.3879","article-title":"PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses.","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s12276-022-00786-0","article-title":"The CDK1\/TFCP2L1\/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.","volume":"54","author":"Heo","year":"2022","journal-title":"Exp Mol Med"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"110836","DOI":"10.1016\/j.cellsig.2023.110836","article-title":"MicroRNA-30c-5p arrests bladder cancer G2\/M phase and suppresses its progression by targeting PRC1-mediated blocking of CDK1\/CyclinB1axis.","volume":"110","author":"Hao","year":"2023","journal-title":"Cell Signal"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/cas.15159","article-title":"Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.","volume":"112","author":"Liu","year":"2021","journal-title":"Cancer Sci"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.7150\/thno.101575","article-title":"SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3\/CCL2\/IL-6 axis and is regulated by VEZF1.","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"365","DOI":"10.14740\/wjon1536","article-title":"Association between Interleukin-6 levels and lymph node metastasis in bladder cancer patients.","volume":"13","author":"Warli","year":"2022","journal-title":"World J Oncol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"e1303","DOI":"10.1634\/theoncologist.2018-0845","article-title":"Emergence of ERBB2 mutation as a biomarker and an actionable target in solid cancers.","volume":"24","author":"Subramanian","year":"2019","journal-title":"Oncologist"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer.","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/cas.14080","article-title":"Exosomes containing ErbB2\/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.","volume":"110","author":"Yoshida","year":"2019","journal-title":"Cancer Sci"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.euo.2023.10.003","article-title":"Prognostic significance of HER2 expression in patients with bacillus Calmette-Gu\u00e9rin-exposed non-muscle-invasive bladder cancer.","volume":"7","author":"Tan","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors.","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R47-20260915","doi-asserted-by":"crossref","first-page":"1584502","DOI":"10.3389\/fphar.2025.1584502","article-title":"Multiscale screening and identifying specific targets for artesunate in suppressing bladder cancer.","volume":"16","author":"Yuan","year":"2025","journal-title":"Front Pharmacol"},{"key":"R48-20260915","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fphar.2018.00366","article-title":"Targeting DNA methyltranferases in urological tumors.","volume":"9","author":"Marques-Magalh\u00e3es","year":"2018","journal-title":"Front Pharmacol"},{"key":"R49-20260915","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bbrc.2017.11.165","article-title":"Lycium barbarum polysaccharide protects against oxygen glucose deprivation\/reoxygenation-induced apoptosis and autophagic cell death via the PI3K\/Akt\/mTOR signaling pathway in primary cultured hippocampal neurons.","volume":"495","author":"Yu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R50-20260915","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-018-1543-2","article-title":"Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1\u03b1-dependent glycolysis through inactivation of the PI3K\/Akt\/mTOR pathway.","volume":"16","author":"Gong","year":"2018","journal-title":"J Transl Med"},{"key":"R51-20260915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12951-021-00935-z","article-title":"Fe-doped chrysotile nanotubes containing siRNAs to silence SPAG5 to treat bladder cancer.","volume":"19","author":"Liu","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"R52-20260915","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy.","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R53-20260915","doi-asserted-by":"crossref","first-page":"e140923221042","DOI":"10.2174\/1874467217666230914090621","article-title":"Targeting mutant-p53 for cancer treatment: are we there yet?","volume":"17","author":"Lim","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"R54-20260915","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.molonc.2016.04.001","article-title":"Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.","volume":"10","author":"Cordani","year":"2016","journal-title":"Mol Oncol"},{"key":"R55-20260915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12013-015-0574-z","article-title":"Bladder cancer and genetic mutations.","volume":"73","author":"Zhang","year":"2015","journal-title":"Cell Biochem Biophys"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:01:17Z","timestamp":1789495277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047378","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"2025-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}